Abstract:Objective To investigate the value of MR perfusion parameters and ADC in the diagnosis of pancreatic cancer and pancreatic mass at 3.0 T MR. Methods Twenty healthy volunteers and 25 patients with pancreatic cancers proven by pathological results underwent MR PWI at a 3.0 T scanner. A two-compartment model was used to quantify Ktrans, Kep and Ve in the pancreatic cancer, adjacent pancreatic tissue, distal inflammatory pancreatic tissue and normal pancreatic tissue. All parameters among different tissues were analyzed and compared with ANONA. Fifteen normal volunteers and 58 patients, including 30 patients with pancreatic cancer (proven histopathologically), 9 patients with pancreatitis pseudotumor (4 patients proven by histopathological results, 5 patients proven by follow-up after treatment), 9 patients with solid pseudopapillary tumor of pancreas (SPTP, proven histopathologically) and 10 patients with pancreatic neuroendocrine tumor (PET, proven by histopathology), underwent respiratory-triggered DWI on 3.0 T. ADC values of normal pancreas and all types of pancreatic lesions were statistically analyzed and compared with ANONA. ROC curve was used to analyze the diagnostic power of ADC value. Results Ktrans of pancreatic cancer, adjacent pancreatic tissue, distal inflammatory pancreatic tissue and normal pancreatic tissue were (1.66±1.25), (3.77±2.67),(1.16±0.94) and (2.69±1.46)/min respectively(F=8.160, P＜0.01). LSD test showed that Ktrans in the pancreatic cancer was statistically lower than that in normal pancreas (P=0.011)and adjacent pancreatic tissue(P=0.002). Kep of pancreatic cancer, adjacent pancreatic tissue, distal inflammatory pancreatic tissue and normal pancreatic tissue were (2.53±1.55), (5.64±2.64), (1.70±0.91) and (4.28±1.64)/min respectively(F=4.544, P＜0.01). LSD test revealed that Kep in pancreatic cancer was statistically lower than that in normal pancreatic tissue (P=0.035)and adjacent pancreatic tissue(P=0.041). The median of Ve among the pancreatic cancer, adjacent pancreatic tissue, distal inflammatory pancreatic tissue and normal pancreatic tissue were 0.926, 0.839, 0.798 and 0.659 respectively (χ2=12.040,P＜0.01). Ve in pancreatic cancer was statistically higher than that in normal pancreatic tissue (P=0.002). ADC values of the pancreatic cancer, pancreatitis pseudotumor, SPTP, PET and normal pancreas were(1.57±0.26)×10-3,(1.19±0.15)×10-3,(1.05±0.35)×10-3,(1.62±0.41)×10-3 and (1.82±0.25)×10-3 mm2/s(F=21.681, P＜0.01). LSD test showed there were significant statistical differences in ADC values among pancreatic cancer, pancreatitis pseudotumor and normal pancreatic tissue (P＜0.01). ROC curve disclosed that the sensitivity, specificity, positive predictive value and negative predictive value were 86.7%, 88.9%, 96.3% and 66.7% respectively, when ADC≥1.33×10-3 mm2/s was used as a cutoff value for differential diagnosis of PDCA from MLP. The sensitivity, specificity, positive predictive value and negative predictive value were 77.8%, 100.0%, 100.0% and 83.3% respectively when ADC≤1.25×10-3 mm2/s was used as a cutoff value for differential diagnosis of SPTP from PET. Conclusion Compared to normal pancreatic tissue, pancreatic cancer usually had a lower Ktrans, Kep and larger Ve. ADC values from respiratory-triggered DWI were well related to histopathological features of pancreatic entities and may be helpful in the differential diagnosis.

Clinical Study on Different Diffusion-Weighted MR Imaging Sequences for Pancreatic Cancer at 3.0 T

Reduced Field-of-view Diffusion-Weighted Imaging (DWI) in Patients with Gastric Cancer

Comparison of reduced field‐of‐view diffusion‐weighted imaging (DWI) and conventional DWI techniques in the assessment of rectal carcinoma at 3.0T: Image quality and histological T staging

The Applied Research on Respiratory-triggered Diffusion-weighted MR Imaging of Pancreatic Carcinoma at 3.0T

Optimization of MR Diffusion-Weighted Imaging Acquisitions for Pancreatic Cancer at 3.0T.

Application of 3.0T-MRI DWI in evaluating the efficacy of synchronous radiotherapy and chemotherapy for advanced lung cancer

Application of 3.0T magnetic resonance diffusion weighted imaging in the advanced gastric cancer

Evaluation of diffusion-weighted MR imaging sequences of normal pancreas at 3.0T

Research on Perfusion Weighted Imaging and Diffusion Weighted Imaging of Pancreatic Masses at 3.0 T MR

The Applied Value of Breath-Holding Diffusion-Weighted MR Imaging for Pancreatic Carcinoma at 3.0 T

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

Comparison of Diffusion-Weighted Mri Acquisition Techniques for Normal Pancreas at 3.0 Tesla

Differentiation of Pancreas Carcinoma from Healthy Pancreas Using Diffusion-Weighted MR Imaging:Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion-Derived Parameters

Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0 T

Diagnostic Value of 3.0T MR Diffusion-Weighted Imaging in Prostate Cancer

Quantitative Study of 3T MRI Qdixon-Wip Applied in Pancreatic Fat Infiltration in Patients with Type 2 Diabetes Mellitus

Value of DWI on differentially diagnosing malignant and benign mucinous cystic neoplasms of pancreas

Comparisons of Image Quality and ADCs in Breath-Hold, Respiratory-Triggered and Free-Breathing DWI of Pancreas at 3-T

MR diffusion weighted imaging of gastric cancer:b-value determination and comparison with routine sequences

Diagnostic value of 3. 0T MR diffusion-weighted imaging in prostate cancer

Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI